Date: Apr 2022
Date: Apr 2022
The Market Statsville Group (MSG) publishes the new report on the "Artificial Cornea and Corneal Implant Market by Type (Human Cornea and Artificial Cornea), by Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty, and Keratoprosthesis), by Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus, and Others), by End-Users (Hospitals & Ambulatory Surgical Center and Specialty Clinics), by Region – Global Share and Forecast to 2030".
The global artificial cornea and corneal implant market size is estimated to grow to USD 706.4 million by 2030 from USD 384.5 million in 2021, growing at a CAGR of 7.9% during the forecast period. A corneal implant involves replacing a cloudy cornea with a clear donor cornea. The artificial cornea implant market is anticipated to grow significantly during the forecast period due to an increase in the incidence of corneal infection. There is an increase in visual disability due to cloudy cornea for working people, which has increased the demand for cornea implants in the global market. In addition, the rise in government initiatives aimed at establishing guidelines to control the global increase in vision impairment is pressuring major manufacturers to introduce novel artificial corneas to the market.
The overall artificial cornea and corneal implant market has been segmented into the type, transplant type, disease indication, end-users, and region.
Penetrating keratoplasty, by transplant type, hold the largest market share
Based on transplant type, the global artificial cornea and corneal implant market is segmented into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and keratoprosthesis. The penetrating keratoplasty segment was the highest contributor to the market, with a market share of 37.5% in 2021. Penetrating keratoplasty (PK) is the traditional method that is used for corneal transplantation, where the central two-thirds of the spoiled cornea is surgically removed and replaced with a healthy cornea from a human donor. PKs are performed primarily for visually significant stromal scarring, opacities with an uncertain status of endothelium or significant posterior corneal involvement, corneal ectasia (such as keratoconus and pellucid marginal degeneration, especially if there is the history of hydrops), combined stromal and epithelial disease (such as Peters anomaly), and infectious or non-infectious corneal ulcerations or perforations.
A rise in awareness about the importance of eye donation is expected to boost market growth. In addition, improving eye care facilities, eye banking framework, and cornea trade protocols in developing countries are expected to contribute to market growth during the forecast period.
North America accounts for the largest market share in artificial cornea and corneal implant market 2021
The report segments the global artificial cornea and corneal implant market according to five key regions: North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. North America dominated the artificial cornea and corneal implant market in 2021. North America had a market share of 41.8%. North America includes the U.S., Canada, and Mexico. The market in North America was dominant, in terms of revenue, among other regions in 2021, owing to a rise in the prevalence of the geriatric population, increase in healthcare infrastructure, and rise in awareness and initiatives taken by governments for eye health. North America has displayed the highest contribution to the global market attributed to its largest number of ophthalmic diagnostic, surgical, and vision correction procedures.
The major causes of blindness and low vision in the U.S. are age-related eye diseases such as diabetic retinopathy, cataract, age-related macular degeneration, and glaucoma. These diseases mentioned above require comprehensive eye examinations of patients to design an effective treatment depending upon eye disorder severity, hence propelling the market growth.
This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the artificial cornea and corneal implant market. It also consists of the profiles of leading companies such as CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc., AJL Ophthalmic, CorneaGen Inc., Mediphacos, Cornea Biosciences, Aurolab, DIOPTEX GmbH, and EyeYon Medical. These market players have focused on acquisitions and expansion to gain a larger market share in the artificial cornea and corneal implant market.
Browse the complete report: https://www.marketstatsville.com/artificial-cornea-and-corneal-implant-market
About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.
Contact Us:
Market Statsville Group
416, East Standsberry Street, Perkins, Oklahoma 74059, USA
USA: +1-580-205-2707 | +91 702 496 8807
Email: sales@marketstatsville.com
Want to Review Complete Market Research Report